期刊文献+

胃癌患者CD4^+CD29^+T细胞表达及其临床意义

Expression and significance of CD4+CD29+T cells for patients with gastric carcinoma
下载PDF
导出
摘要 目的探讨CD4+CD29+辅助性T细胞在胃癌患者中的表达及其临床意义。方法收集Ⅰ~Ⅳ期胃癌患者共64例、慢性胃炎患者及健康对照组各60例作为观察对象。采用流式细胞术检测外周血CD4+CD29+T细胞及其细胞因子γ干扰素(IFN-γ)及白介素4(IL-4)水平;采用ELISA法检测三组的细胞间黏附分子-1(ICAM-1)、转化生长因子β1(TGF-β1)及癌胚抗原(CEA)的含量;分析以上六者的相关性。结果胃癌患者CD4+CD29+T细胞及IL-4水平显著高于慢性胃炎及健康对照组(P<0.05),而IFN-γ明显低于另外两组(P<0.05),但慢性胃炎与健康对照组上述三项指标无统计学差异。Ⅰ~Ⅳ期胃癌患者CD4+CD29+T细胞及IL-4呈递增趋势,而IFN-γ呈递减趋势,均表现为Ⅲ与Ⅰ期之间、Ⅳ与Ⅲ期之间均存在显著差异(P<0.05)。胃癌患者ICAM-1、TGF-β1及CEA显著高于慢性胃炎及健康对照组(P<0.05),但慢性胃炎与健康对照组上述三项指标无统计学差异。相关性分析显示CD4+CD29+T细胞及IL-4两者与ICAM-1、TGF-β1及CEA三者当中任意一者均呈正相关性,而IFN-γ与ICAM-1、TGF-β1及CEA三者当中任意一者均呈负相关性(P<0.05)。结论 CD4+CD29+T细胞及IL-4表达增加、IFN-γ表达减少是胃癌患者的一个重要免疫学特征,在早晚期胃癌呈显著差异性表达,且三者与胃癌的血管表达相关因子密切相关。 Objective To explore the expression and significance of CD4^+CD29^+T cells for patients with gastric carcinoma. Methods Sixty-four patients with gastric cancer, including I -IV stage, were enrolled, as well 60 chronic gastritis patients and healthy subjects. The peripheral blood CD4^+CD29^+T cells and cytokines T-interferon (IFN-γ) and interleukin 4 (IL-4) were tested using flow cytometry. The levels of intercellular adhesion molecule 1 (ICAM- 1), transforming growth factor beta 1 (TGF-beta 1) and carcinoembryonic antigen (CEA) were also tested. The correlation between the above-mentioned 6 indexes was analyzed via Pearson test. Results The percentage of CD4^+CD29^+ T cells and mean fluorescence intensity of IL-4 of the gastric cancer patients were higher than those in the chronic gastritis and healthy subjects (P〈0.05); whereas the mean fluorescence intensity of IFN-γ were lower than the other two groups for the gastric cancer patients. CD4^+CD29^+T cells and IL-4 increased and but IFN-γ decreased for the I to IV stage gastric cancer patients, and the levels of ICAM-1, TGF-131and CEA also increased when compared with the other two groups (P〈0.05). Pearson analysis showed that CD4^+CD29^+F cells and IL-4 positively correlate with CAM-l, TGF-β1 and CEA; but IFN-γ negatively correlate with CAM-1, TGF-β1 and CEA (P〈0.05). Conclusion Increase of CD4^+CD29^+T cells and IL-4, as well the decrease of IFN-γ were the important immunological features for gastric cancer patients. CD4^+CD29^+T cells, IL-4 and IFN-γ were differently expressed in early and end stages for patients with gastric carcinoma significantly, and they correlated with the factors which are closely related the tumor angiogenesis.
出处 《岭南现代临床外科》 2014年第4期394-397,共4页 Lingnan Modern Clinics in Surgery
基金 广东省湛江市科技计划项目(编号:2009C3103016)
关键词 胃癌 CD4^+CD29^+T细胞 细胞因子 血管生成 相关性分析 Gastric carcinoma CD4^+CD29^+T cells Cytokines Angiogenesis Correlation analysis
  • 相关文献

参考文献11

二级参考文献98

  • 1王凌云,黄开红,闵军,苏红,朱兆华.胃癌患者外周血调节性T细胞的多种细胞因子水平的检测及其意义[J].中华实验外科杂志,2006,23(11):1375-1377. 被引量:18
  • 2张信华,何裕隆,詹文华,蔡世荣,张常华.胃肠间质瘤135例临床诊治分析[J].中华胃肠外科杂志,2007,10(1):17-20. 被引量:38
  • 3曾冬竹,余佩武,雷晓,石彦,王自强,郑峻松.CD4^+ CD25^+调控T细胞对小鼠胃癌的影响[J].中华胃肠外科杂志,2007,10(4):368-371. 被引量:7
  • 4Watanabe N, Kawashima H, Li YF, et al. Identification and characterization of llgands for L-selectinin in thv kidney, Ⅲ. Characterization of L-selecfin reactive heparan sulfate proteoglycans [ J ]. Biochem, 1999, 125(4) :93-99.
  • 5Gioffl M, Gazzerro P, Finizio BD, et al. Serum soluble SE-cadherin fragments in lung cancer[J]. Tumor, 85(1 ) :32-34.
  • 6BendardafR, Elzagheid A, Lamlum H, et al. E.-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer[ J]. Oncol Rep, 2005,13(5) :831-835.
  • 7Stecber DA, Tang ML, Green NE, et al. Leukocyte entry into sites of inflammation requires over tapping interactions between the L-Selection and ICAM-1 pathwasy[J]. Immunol, 1999,163(4) :2176-2179.
  • 8Lukita AW, Machen NW. Effect of intravenous immunoglobulin 6 on the TNF alpha-medicated hepatic microvascular inflammatory response [J]. Shock, 1999,11(2) :291-297.
  • 9Grignol VP, Termuhlen PM. Gastrointestinal stromal tumor surgery and adjuvant therapy [ J ]. Surg Clin North Am, 2011,91 (5):1079.
  • 10Chang H, Schimmer AD. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy[ J]. Mol Cancer Ther,2007,6( 1 ) :24.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部